GAO Slams FDA For Lax Monitoring Of Foreign Drugs

Law360, New York (November 1, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has failed to tighten up and improve its safety oversight of the foreign drugs entering the country, suggesting a gaping hole in the agency's security methods, according to the Government Accountability Office.

On Thursday, the GAO presented its findings to Congress, warning lawmakers that the FDA had done little to address the safety concerns first raised by the watchdog nine years ago.

“FDA’s effectiveness in managing the foreign drug inspection program continues to be hindered by weaknesses in its databases,”...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.